Search Result "anti-B cell therapy"
The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 1 Year: 2012 Page: 1512-1518
Author(s): Diana S. Novikova, Tatyana V. Popkova, Eugeny L. Nasonov
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art
Journal: Current Drug Targets
Volume: 17 Issue: 9 Year: 2016 Page: 1072-1082
Author(s): Magdalena Witkowska, Piotr Smolewski
Current Perspectives on Cytokines for Anti-retroviral Therapy in AIDS Related B-cell Lymphomas
Journal: Current Drug Targets - Infectious Disorders
Volume: 3 Issue: 2 Year: 2003 Page: 137-149
Author(s): V. Sharma
Hematopoietic Stem Cells Therapies
Journal: Current Stem Cell Research & Therapy
Volume: 12 Issue: 2 Year: 2017 Page: 124-133
Author(s): Mihaela Chivu-Economescu,Martin Rubach
Promising Therapies in Sickle Cell Disease
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 1-8
Author(s): Radha Raghupathy, Henny H. Billett
Cardiac Cell Therapy and Bypass Surgery
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3348-3355
Author(s): Yeong-Hoon Choi, Boris Nasseri, Christof Stamm
Design and Development of Anti-Hepatitis B Virus Agents
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 3377-3392
Author(s): S. Kaushik, S. P. Gupta, P. K. Sharma
Cell Therapy for Myocardial Regeneration
Journal: Current Molecular Medicine
Volume: 9 Issue: 3 Year: 2009 Page: 287-298
Author(s): Jia Liu, Joost P.G. Sluijter, Marie-Jose Goumans, Anke M. Smits, Tycho van der Spoel, Hendrik Nathoe, Pieter A. Doevendans
Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549)
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 6 Year: 2019 Page: 802-819
Author(s): Cody P. Coyne,Lakshmi Narayanan
Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 6 Issue: 4 Year: 2006 Page: 345-350
Author(s): Robert Eisenberg